Neurogen Corporation Announces Webcast of June 13 Presentation at Needham Biotechnology Investor Conference

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced today that William H. Koster, President and CEO, will present a Company overview at the Sixth Annual Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 13 at 2:00 p.m. EDT.

MORE ON THIS TOPIC